| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | W M Korn | |
| P2860 | cites work | Restoration of tight junction structure and barrier function by down-regulation of the mitogen-activated protein kinase pathway in ras-transformed Madin-Darby canine kidney cells | Q34690508 |
| Invasiveness of hepatocellular carcinoma cell lines: contribution of membrane-type 1 matrix metalloproteinase | Q34786196 | ||
| Classification of hepatocellular carcinoma according to hepatocellular and biliary differentiation markers. Clinical and biological implications. | Q35782193 | ||
| Activation of the Met receptor by cell attachment induces and sustains hepatocellular carcinomas in transgenic mice | Q36326357 | ||
| Prediction of recurrence and extratumor spread of hepatocellular carcinoma following resection | Q40732524 | ||
| Is the pathologic TNM staging system for patients with hepatoma predictive of outcome? | Q40780775 | ||
| TGF-beta1 and Ha-Ras collaborate in modulating the phenotypic plasticity and invasiveness of epithelial tumor cells | Q41164260 | ||
| Genome-wide analysis of gene expression in human hepatocellular carcinomas using cDNA microarray: identification of genes involved in viral carcinogenesis and tumor progression. | Q43030699 | ||
| Adjuvant chemotherapy after resection of hepatocellular carcinoma causes deterioration of long-term prognosis in cirrhotic patients: metaanalysis of three randomized controlled trials | Q43645553 | ||
| Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival | Q46743120 | ||
| Hepatocellular carcinoma results from chronic cyclin D1 overexpression in transgenic mice | Q49230994 | ||
| Disruption of the pRb/E2F pathway and inhibition of apoptosis are major oncogenic events in liver constitutively expressing c-myc and transforming growth factor alpha. | Q52528675 | ||
| Clinicopathologic features and prognosis of resected hepatocellular carcinomas of varied sizes with special reference to proliferating cell nuclear antigen | Q71067198 | ||
| Proliferating cell nuclear antigen and grade of malignancy in small hepatocellular carcinoma--evaluation in US-guided specimens | Q73127316 | ||
| Invasion and metastasis of hepatocellular carcinoma in relation to urokinase-type plasminogen activator, its receptor and inhibitor | Q73193733 | ||
| Clinicopathologic analysis of stage II-III hepatocellular carcinoma showing early massive recurrence after liver resection | Q73269069 | ||
| Serum vascular endothelial growth factor predicts venous invasion in hepatocellular carcinoma: a prospective study | Q73435945 | ||
| Autocrine stimulatory mechanism by transforming growth factor beta in human hepatocellular carcinoma | Q73574342 | ||
| Immunoreactive E-cadherin, alpha-catenin, beta-catenin, and gamma-catenin proteins in hepatocellular carcinoma: relationships with tumor grade, clinicopathologic parameters, and patients' survival | Q73847008 | ||
| Increased expression of vascular endothelial growth factor in human hepatocellular carcinoma | Q73908738 | ||
| Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma | Q74130358 | ||
| Transforming growth factor-alpha and epidermal growth factor receptor in chronic liver disease and hepatocellular carcinoma | Q78164876 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 777-778 | |
| P577 | publication date | 2001-12-01 | |
| P1433 | published in | World Journal of Gastroenterology | Q15708885 |
| P1476 | title | Moving toward an understanding of the metastatic process in hepatocellular carcinoma | |
| P478 | volume | 7 |
| Q21285158 | Biomarkers for hepatocellular carcinoma |
| Q33241639 | Correlation between CD105 expression and postoperative recurrence and metastasis of hepatocellular carcinoma |
| Q36309190 | Experimental study of anti-tumor effects of polysaccharides from Angelica sinensis |
| Q36309178 | Expression and significance of RhoC gene in hepatocellular carcinoma |
| Q34294657 | Hemizygous deletion and hypermethylation of RUNX3 gene in hepatocellular carcinoma |
| Q39419949 | Micronutrient Synergy in the Fight against Hepatocellular Carcinoma |
| Q26824909 | Novel hepatocellular carcinoma molecules with prognostic and therapeutic potentials |
| Q37311888 | Pigment epithelium-derived factor and matrix metalloproteinase-9 in liver cirrhosis |
| Q36066025 | Prognostic and clinicopathological features of E-cadherin, alpha-catenin, beta-catenin, gamma-catenin and cyclin D1 expression in human esophageal squamous cell carcinoma |
| Q35810123 | Recent progress in predictive biomarkers for metastatic recurrence of human hepatocellular carcinoma: a review of the literature |
| Q36178395 | Relationship between expression of E-cadherin-catenin complex and clinicopathologic characteristics of pancreatic cancer |
| Q36961950 | Serum Levels of Interleukin-6 and Interleukin-10 as Biomarkers for Hepatocellular Carcinoma in Egyptian Patients |
| Q34668320 | The prognostic molecular markers in hepatocellular carcinoma |
Search more.